More from Investing
The GPU giant has steadily grown its addressable market, in part by creating end-to-end solutions that pair its chips with complementary software.
The sudden drop and weak close Tuesday were not favorable despite a lack of technical damage.
In an updated daily bar chart, we can see that prices have been strong all month.
A little bit of luck and a lot of homework can go a long way to make Big Money out of Mad Money. It's buying a Biogen, a Centene, or a Bristol-Myers that could do just that for you.